and after heterocycle formation, in addition to its fundamental
role as a link to the support.4
In this letter, we further explore the potential of our linker
system in an approach to tetrahydroquinolones.
The tetrahydroquinolone framework can be found in many
natural and nonnatural biologically active compounds and
is therefore an attractive scaffold for synthesis (Figure 1).5
were prepared in which the benzyl sulfanyl group mimics a
benzylic sulfur resin. Although few Heck reactions of N-R-
halophenylamides and carbamates have been reported,6 both
5 and 6 underwent efficient Heck coupling in o-xylene with
tert-butyl acrylate under microwave conditions. Oxidation
of 7 and 8 to the corresponding sulfones and treatment with
K2CO3 gave the anti-tetrahydroquinolones 9 and 10 in good
yield. The relative stereochemistry of 9 and 10 was confirmed
by X-ray crystallography.7 The cleavage reaction was next
investigated in the model system. We have previously shown
that cleavage of the linker can be carried out at both the
sulfide and sulfone oxidation levels.4 Treatment of 9 and 10
with SmI2 using LiCl as a promotor8 gave the expected
products in moderate, unoptimized yields. Further modifica-
tion of 9 was readily achieved by alkylation to give 13, the
relative stereochemistry of which was confirmed by X-ray
crystallography.7 Cleavage using SmI2/LiCl gave 14 as a
∼1:1 mixture of diastereoisomers. Interestingly, the use of
t-BuOH as a proton source in the reduction gave syn-14 as
the major product (5:1 diastereoisomeric ratio) (Scheme 3).
Scheme 3
Figure 1. Tetrahydroquinolone framework.
Our proposed, solid-phase approach to tetrahydroquinolones
1 is outlined in Scheme 2. Heck reactions of immobilized
Scheme 2
The relative stereochemistry of the major diastereoisomer
was confirmed by X-ray crystallography.7
(5) (a) Patel, M.; McHugh, R. J., Jr.; Cordova, B. C.; Klabe, R. M.;
Bacheler, L. T.; Erickson-Viitanen, S.; Rodgers, J. D. Biorg. Med. Chem.
Lett. 2001, 11, 1943. (b) Hayashi, H.; Miwa, Y.; Miki, I.; Ichikawa, S.;
Yoda, N.; Ishii, A.; Kono, M.; Suzuki, F. J. Med. Chem. 1992, 35, 4893.
(c) Carling, R. W.; Leeson, P. D.; Moore, K. W.; Smith, J. D.; Moyes, C.
R.; Mawer, I. M.; Thomas, S.; Chan, T.; Baker, R.; Foster, A. C.; Grimwood,
S.; Kemp, J. A.; Marshall, G. R.; Tricklebank, M. D.; Saywell, K. L. J.
Med. Chem. 1993, 36, 3397. (d) Christopher, E.; Bedir, E.; Dunbar, C.;
Khan, I. A.; Okunji, C. O.; Schuster, B. M.; Iwu, M. M. HelV. Chim. Acta
2003, 86, 2914. (e) Ito, C.; Itoigawa, M.; Otsuka, T.; Tokuda, H.; Nishino,
H.; Furukawa, H. J. Nat. Prod. 2000, 63, 1344.
aryl halides 4 with electron-deficient alkenes should allow
access to key intermediates 3. Base-mediated cyclization will
then furnish the tetrahydroquinolone core 2 which can be
modified before cleavage from the support.
We began our studies by evaluating the route using a
solution-phase model system. R-Sulfanyl amides 5 and 6
(6) For an example, see: Arnold, L. A.; Luo, W.; Guy, R. K. Org. Lett.
2004, 6, 3005.
(7) See Supporting Information for X-ray structures and CCDC num-
bers.
(4) (a) McAllister, L. A.; Brand, S.; de Gentile, R.; Procter, D. J. Chem.
Commun. 2003, 2380. (b) McAllister, L. A.; McCormick, R. A.; Brand, S.;
Procter, D. J. Angew. Chem., Int. Ed. 2005, 44, 452.
330
Org. Lett., Vol. 8, No. 2, 2006